KMYY(SH:600518)2018-04-27 16:00Financial Performance - Net profit attributable to shareholders rose by 33.28% to CNY 1.42 billion year-on-year[5] - Operating revenue grew by 27.68% to CNY 9.14 billion compared to the same period last year[5] - Basic earnings per share increased by 32.72% to CNY 0.288 per share[5] - The weighted average return on equity improved by 0.78 percentage points to 4.78%[5] - Total operating revenue for Q1 2018 reached ¥9,135,184,162.23, a 27.7% increase from ¥7,154,664,663.12 in the same period last year[28] - Net profit for Q1 2018 was ¥1,417,202,695.15, representing a 32.9% increase compared to ¥1,065,567,775.65 in Q1 2017[29] - Total comprehensive income for the first quarter of 2018 was CNY 1,429,329,720.35, compared to CNY 1,021,435,519.52 in the same period last year, representing an increase of approximately 40%[33] Assets and Liabilities - Total assets increased by 5.05% to CNY 72.19 billion compared to the end of the previous year[5] - Total current assets increased to ¥59.80 billion from ¥56.48 billion, a growth of approximately 4.1%[21] - Total non-current assets amounted to ¥12.39 billion, up from ¥12.24 billion, indicating a growth of about 1.2%[22] - Total liabilities increased to ¥38.59 billion from ¥36.59 billion, a rise of about 5.5%[23] - The company's equity attributable to shareholders increased to ¥33.50 billion from ¥32.03 billion, a growth of approximately 4.6%[23] Cash Flow - Net cash flow from operating activities decreased by 27.23% to CNY 982.05 million[5] - Cash inflow from operating activities totaled CNY 9,023,172,069.43, compared to CNY 7,580,515,031.68 in the prior year, marking an increase of about 19%[34] - Cash outflow from operating activities was CNY 8,041,124,087.74, up from CNY 6,230,988,167.28, which is an increase of approximately 29%[34] - Cash flow from financing activities generated a net inflow of CNY 1,933,713,296.90, compared to CNY 1,721,038,446.03 in the same period last year, reflecting an increase of about 12.3%[34] Shareholder Information - The number of shareholders reached 101,610 at the end of the reporting period[10] - The largest shareholder, Kangmei Industrial Investment Holdings, holds 32.98% of the shares[10] - Total number of preferred shareholders is 8[13] - The top ten preferred shareholders hold a total of 30% (9,000,000 shares) by Bosera Fund and 20% (6,000,000 shares) by Huashang Fund[14] Expenses - Employee compensation payable decreased by 41.50% to 63,080,397.98 RMB from 107,838,240.46 RMB[15] - Sales expenses increased by 79.78% to 249,066,505.07 RMB compared to 138,540,794.26 RMB in the previous period[15] - Financial expenses rose by 39.46% to 308,783,481.31 RMB from 221,411,275.96 RMB[15] Investments - The company has invested 33,046,429.39 RMB (1.10% of the budget) in the China-ASEAN Traditional Chinese Medicine Trading Center project[16] - The Gansu Dingxi Traditional Chinese Medicine Logistics and Trading Center project has seen 748,607,779.99 RMB invested, representing 68.06% of the budget[17] - The company has budgeted 1,000,000,000 RMB for the second phase of the Kangmei (Bozhou) Huatuo International Chinese Medicine City project, with 1,315,487,534.81 RMB already invested (131.55% of the budget)[17] - The Qinghai International Chinese Medicine City project has a budget of 850,000,000 RMB, with 1,187,097,533.35 RMB invested (139.66% of the budget)[18] Impairment and Gains - Non-recurring gains and losses totaled CNY 6.16 million for the period[7] - Asset impairment losses surged by 25,858.41% to 46,862,115.97 RMB from 180,527.71 RMB[15]